Female Urogenital Diseases and Pregnancy Complications

217 trials 111 recruiting

Filter these 217 trials by phase, country and sponsor.

Open in Search →

A Phase I, open-label study in healthy adults comparing the availability in the body of the active substance lidocaine following administrat… Recruiting

2026-525752-29-00 bioavailability trial with healthy participants, therap 2 2026-06-01
Prospective randomized study on sexual health and self-perceived quality of life (PROMs) in patients treated for cervical cancer Recruiting

2025-521460-36-00 Cervical cancer 6 2026-05-08
Use of a new diagnostic tool in the detection and characterization of endometriosis lesions. ENDO-TEP Recruiting

2025-520637-24-00 Endometriosis 4 2026-03-23
A Study Testing a New Targeted Drug (TUB-040) in combination with Standard Chemotherapy for Women with Ovarian Cancer Recruiting

2025-524691-33-00 High-grade epithelial serous or endometrioid epithelial 9 2026-03-09
A Phase 1 Study for ZW191 in Participants with Solid Tumors Recruiting

2024-512299-37-00 Advanced solid tumors 1 2026-02-18
To evaluate the pharmacokinetics and safety of nolasiban Recruiting

2025-523706-32-00 not applicable (submitted trial is a pharmacokinetic st 3 2026-02-17
Pilot Study to Evaluate Safety and Efficacy of PolyCore, a Ternary Combination of Xylitol, L-Carnitine and Polydextrin, to Treat End-Stage K… Recruiting

2024-519366-52-00 End-Stage Kidney Disease 4 2026-02-17
A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight (RESTRAIN-SUI) Recruiting

2025-522514-23-00 Urinary Incontinence 5 2026-02-12
Pembrolizumab plus Lenvatinib in vulvar cancer patients: The prospective, multi-cohorts and multicentre, phase 2 MITO VULVA-01 study. Recruiting

2023-509180-24-00 vulvar cancer 4 2026-02-12
Evaluation of the Analgesic Effect of Intramyometrial Botulinum Toxin Injection via Hysteroscopy in Severe Primary Dysmenorrhea: A Prospecti… Recruiting

2025-520638-53-00 Severe primary dysmenorrhea 5 2026-02-09
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer with Disease Progression on or Af… Recruiting

2025-522400-24-00 Metastatic urothelial cancer 10 2026-01-27
Effect of Semaglutide on embryo quality in overweight and obese patients undergoing In Vitro Fertilization. A Randomized Controlled Trial Recruiting

2025-522525-34-00 Infertility 6 2026-01-19
STATIN-PRE trial Recruiting

2024-519853-12-00 intrauterine growth restriction 5 2026-01-14
Pilot Study on Subcutaneously Administered Immunotherapy for the Treatment of Cervical Cancer Recruiting

2025-521771-31-00 Cervical Cancer 3 2026-01-05
Clobetasol, mometasone and tacrolimus therapy in the treatment of vulval lichen sclerosus in the pediatric population. Recruiting

2024-514003-33-00 Patients with clinically diagnosed lichen sclerosus of 5 2025-12-29
Hysteroscopic resection versus medical management of early pregnancy loss (HyME): a randomized controlled trial Recruiting

2024-520166-63-00 Early pregnancy loss (< 10 weeks of gestation) 11 2025-12-18
Using a fixed dosage of follitropin delta for ovarian stimulation for intrauterine insemination. Recruiting

2025-520681-22-00 Infertility 4 2025-12-17
A phase I Study to Assess the Safety and Tolerability of MBF-362 in Healthy Women, and Preliminary Efficacy in Otherwise Healthy Women diagn… Recruiting

2025-521809-40-00 Primary Dysmenorrhea 3 2025-12-10
A Clinical Trial of Tirzepatide (LY3298176) in Subjects With Overweight or Obesity and PCOS-related Ovarian Dysfunction (PERIODS) Recruiting

2024-515982-32-00 Overweight or Obesity 6 2025-12-09
A Phase 2 trial to investigate efficacy and safety of vipoglanstat in women with endometriosis Recruiting

2025-522452-16-00 Endometriosis related pain 4 2025-12-05
VALIDATION OF THE SENTINEL LYMPH NODE TECHNIQUE IN EARLY-STAGE OVARIAN CANCER (SENTOV II) Recruiting

2024-520189-67-00 OVARIAN CANCER 5 2025-10-08
A study to learn about nadofaragene firadenovec given alone or together with gemcitabine and docetaxel or, pembrolizumab in adults with non-… Recruiting

2024-512177-27-01 High-risk Bacillus Calmette-Guerin (BCG)-unresponsive n 5 2025-09-29
CLEARTOX: Development of an innovative haemodialysis method to improve dialytic clearance of protein-bound uraemic toxins Recruiting

2023-510406-41-00 chronic hemodialysis patients (for more than 3 months) 4 2025-09-22
Metformin for the prolongation of pregnancy in preterm preeclampsia: the PI-NL trial Recruiting

2023-510382-10-00 HELLP syndrome 5 2025-08-25